Latest News, Announcements, and Press Releases

Investment to fund strategic growth initiatives across the diverse and expanding synthetic biology end market REDWOOD CITY, Calif. , June 20, 2019 (GLOBE NEWSWIRE) — Codexis, Inc. (Nasdaq: CDXS), a leading synthetic biology company, announces that Casdin Capital, LLC ,…

REDWOOD CITY, Calif. , May 30, 2019 (GLOBE NEWSWIRE) — Codexis, Inc. (NASDAQ: CDXS), a leading protein engineering company, announces that management will present at the Jefferies 2019 Global Healthcare Conference on Thursday, June 6 at 2:30 p.m. Eastern time…

Third CodeEvolver® licensing agreement with a major pharma company REDWOOD CITY, Calif. , May 15, 2019 (GLOBE NEWSWIRE) — Codexis, Inc. (Nasdaq: CDXS), a leading protein engineering company, announces the signing of a CodeEvolver ® platform agreement with Novartis .

REDWOOD CITY, Calif. , May 14, 2019 (GLOBE NEWSWIRE) — Codexis, Inc. (NASDAQ: CDXS), a leading protein engineering company, announces that management will participate in three upcoming investment conferences: UBS Global Healthcare Conference on May 21 at 8:00 a.m.

Total revenues increase 11% to $15.6 million , product revenue up 30% Recent highlights include Third CodeEvolver ® Platform Technology Agreement and Multi-Year Enzyme Supply and Licensing Agreement with Tate & Lyle for TASTEVA ® M Stevia Sweetener Conference call…

Codexis’ breakthrough enzyme cascade system enables better-tasting stevia product launch REDWOOD CITY, Calif. , April 30, 2019 (GLOBE NEWSWIRE) — Codexis, Inc. (NASDAQ: CDXS), a leading protein engineering company, announces the signing of a multi – year agreement with Tate…

REDWOOD CITY, Calif. , April 29, 2019 (GLOBE NEWSWIRE) — Codexis, Inc. (NASDAQ: CDXS), a leading protein engineering company, announces that it will report first quarter 2019 financial results after market close on Monday, May 6, 2019 . Codexis management…

REDWOOD CITY, Calif. , April 05, 2019 (GLOBE NEWSWIRE) — Codexis, Inc. (NASDAQ: CDXS), a leading protein engineering company, announces that Jim Lalonde , Ph.D., Senior Vice President of Research and Development, will resign effective May 31, 2019 to pursue…

REDWOOD CITY, Calif. , March 05, 2019 (GLOBE NEWSWIRE) — Codexis, Inc. (NASDAQ: CDXS), a leading protein engineering company, announces that management will participate in two upcoming investment conferences: Cowen and Company 39 th Annual Health Care Conference on Tuesday,…

2018 revenues of $61 million include a 50% increase in R&D revenue  Introduces 2019 financial guidance Conference call begins at 4:30 pm Eastern time today Accompanying slide presentation available on Investor section of company website REDWOOD CITY, Calif. , Feb.